How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Calcium ascorbate dihydrate CAS 5743-28-2 Market
- By Application: Food and Beverage Additives, Dietary Supplements, Pharmaceuticals, Cosmetics and Personal Care, Animal Feed
- By Form: Powder, Granules, Tablet
- By Purity Grade: Food Grade, Pharmaceutical Grade, Industrial Grade
- By Packaging Type: Bags, Drums, Bulk Containers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Food and Beverage Additives leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 268 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.161 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.169 →
Full report · locked preview
Everything inside the Calcium ascorbate dihydrate CAS 5743-28-2 Market report
A complete, evidence-based study - 11 chapters and 112 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Application 5
Form 3
Purity Grade 3
Packaging Type 3
Companies profiled
BASF SE
DSM Nutritional Products
Jiangsu Yabang Dyestuff Chemical
Shandong Luwei Pharmaceutical Co. Ltd.
Jiangxi Tianxin Pharmaceutical Co. Ltd.
Jiangsu Yongjian Pharmaceutical Co. Ltd.
Hebei Welcome Pharmaceutical Co. Ltd.
Jiangsu Hengrui Medicine Co. Ltd.
Zhejiang NHU Co. Ltd.
Wuhan Yuancheng Gongchuang Technology Co. Ltd.
Hubei Xingfa Chemicals Group Co. Ltd.
Jiangsu Jichun Pharmaceutical Co. Ltd.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →DSM Nutritional Products
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Jiangsu Yabang Dyestuff Chemical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Shandong Luwei Pharmaceutical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Jiangxi Tianxin Pharmaceutical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Jiangsu Yongjian Pharmaceutical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Hebei Welcome Pharmaceutical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Jiangsu Hengrui Medicine Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Zhejiang NHU Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Wuhan Yuancheng Gongchuang Technology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Hubei Xingfa Chemicals Group Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Jiangsu Jichun Pharmaceutical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Shandong Xinhua Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Jiangsu Yabang Dyestuff Chemical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Hebei Yipin Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,675M by 2033 · 6.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Food and Beverage Additives39.1
- Dietary Supplements14.5
- Pharmaceuticals19.9
- Cosmetics and Personal Care14.6
- Animal Feed11.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,097M → $1,735M · 5.9%
Europe$764.7M → $1,191M · 5.7%
Asia Pacific$698.2M → $1,295M · 8.0%
Latin America$432.2M → $784.2M · 7.7%
Middle East and Africa$332.5M → $509.2M · 5.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.872026
6.872027
6.902028
6.892029
6.922030
6.922031
6.932032
6.942033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE21.7
- DSM Nutritional Products23.2
- Jiangsu Yabang Dyestuff Chemical5.2
- Shandong Luwei Pharmaceutical Co. Ltd.5.2
- Jiangxi Tianxin Pharmaceutical Co. Ltd.6.3
- Jiangsu Yongjian Pharmaceutical Co. Ltd.10.3
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Application17.2%
Form11.5%
Purity Grade34.2%
Packaging Type37.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.5
- Europe21.6
- Asia Pacific23.5
- Latin America14.2
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 93 | 80 | 84 | 82 | 95 | 85 | 87 |
| DSM Nutritional Products | 92 | 72 | 92 | 93 | 71 | 90 | 85 |
| Jiangsu Yabang Dyestuff Chemical | 82 | 71 | 84 | 86 | 72 | 77 | 79 |
| Shandong Luwei Pharmaceutical Co. Ltd. | 78 | 59 | 69 | 71 | 82 | 69 | 71 |
| Jiangxi Tianxin Pharmaceutical Co. Ltd. | 62 | 56 | 61 | 59 | 65 | 63 | 61 |
| Jiangsu Yongjian Pharmaceutical Co. Ltd. | 59 | 47 | 50 | 51 | 68 | 56 | 55 |
| Hebei Welcome Pharmaceutical Co. Ltd. | 65 | 45 | 45 | 52 | 59 | 47 | 52 |
| Jiangsu Hengrui Medicine Co. Ltd. | 44 | 36 | 44 | 50 | 47 | 41 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- DSM Nutritional Products
- Jiangsu Yabang Dyestuff Chemical
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| DSM Nutritional Products | ✓ | ◐ | ✓ | ✓ | − | ◐ |
| Jiangsu Yabang Dyestuff Chemical | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Shandong Luwei Pharmaceutical Co. Ltd. | ✓ | − | ◐ | ◐ | ◐ | ◐ |
| Jiangxi Tianxin Pharmaceutical Co. Ltd. | − | − | ◐ | − | − | ◐ |
| Jiangsu Yongjian Pharmaceutical Co. Ltd. | − | ◐ | − | − | ◐ | ◐ |
| Hebei Welcome Pharmaceutical Co. Ltd. | − | ◐ | − | ◐ | ◐ | ◐ |
| Jiangsu Hengrui Medicine Co. Ltd. | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE87
2DSM Nutritional Products85
3Jiangsu Yabang Dyestuff Chemical79
4Shandong Luwei Pharmaceutical Co. Ltd.71
5Jiangxi Tianxin Pharmaceutical Co. Ltd.61
6Jiangsu Yongjian Pharmaceutical Co. Ltd.55
7Hebei Welcome Pharmaceutical Co. Ltd.52
8Jiangsu Hengrui Medicine Co. Ltd.44
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
BASF SEDSM Nutritional ProductsJiangsu Yabang Dyestuff Chemical
Challenger1
Strong scale, closing on the leaders.
Shandong Luwei Pharmaceutical Co. Ltd.
Contender1
Focused players with pockets of strength.
Jiangxi Tianxin Pharmaceutical Co. Ltd.
Niche3
Specialists in a single segment or region.
Jiangsu Yongjian Pharmaceutical Co. Ltd.Hebei Welcome Pharmaceutical Co. Ltd.Jiangsu Hengrui Medicine Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Calcium ascorbate dihydrate CAS 5743-28-2 Market — a $355M beachhead inside a $5.12B market.
Beachhead (SOM)$355Mobtainable near-term
Serviceable (SAM)$1.99Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Food and Beverage Additives
Best fit — highest urgency & budget in Application.
Economic buyer78 fit
Dietary Supplements
Strong fit — clear ROI and a fast path to value.
End user66 fit
Pharmaceuticals
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Purity Grade
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel27%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Calcium ascorbate dihydrate CAS 5743-28-2 Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified23%
Evaluation14%
Closed-won8%
$20.1KCAC
$72KLTV
3.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Calcium ascorbate dihydrate CAS 5743-28-2 Market is a durable-growth opportunity — $6.03B by 2033, compounding at 6.0%.
TAM · 2025$3.77Btoday
TAM · 2033$6.03Bforecast
CAGR6.0%2027–2033
Cumulative$43.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.03BTotal addressable market
SAM$2.38BServiceable available market
SOM$427MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.0% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.03BLarge & growingTAM by 2033 at 6.0% CAGR
$2.38BServiceable nowreachable with today’s model
$427MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.70BBear3.9% CAGR
$6.03BBase6.0% CAGR
$7.71BBull8.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Calcium ascorbate dihydrate CAS 5743-28-2 Market — a $1.53B market by 2033. Plan: grow share from 8.5% to 17.5%.
Market size · 2033$1.53Btotal addressable
Market CAGR8.3%2027–2033
Target share17.5%from 8.5% today
Revenue ambition$268Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.5% | 17.5% | On track |
| Revenue | $140M | $268M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 35.3% | 43.1% | On track |
| Customer retention | 85.1% | 92.1% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $35M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Calcium ascorbate dihydrate CAS 5743-28-2 Market conversation — a $9.70B market you can size, segment and defend in minutes.
Market size · 2033$9.70Btotal opportunity
Growth9.0%CAGR to 2033
Addressable buyers1,025+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 2 mopayback period
$82K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
BASF SEDSM Nutritional ProductsJiangsu Yabang Dyestuff ChemicalShandong Luwei Pharmaceutical Co. Ltd.Jiangxi Tianxin Pharmaceutical Co. Ltd.Jiangsu Yongjian Pharmaceutical Co. Ltd.Hebei Welcome Pharmaceutical Co. Ltd.Jiangsu Hengrui Medicine Co. Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Calcium ascorbate dihydrate CAS 5743-28-2 Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Calcium ascorbate dihydrate CAS 5743-28-2 Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Calcium Borate Nanoparticles Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportCalcium Borate Phosphate Market
Market size, share, segmentation and regional forecast.
$318M market · 2025 base year
View reportCalcium Borate Silicate Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportCalcium Borate Stone Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportCalcium Borosilicate Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportCalcium Bromide Brine Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportCALCIUM BUTYRATE CAS 5743-36-2 Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportCalcium Carbide (CaC2) Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportCalcium Carbonate Plastic Pellet Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportCalcium Chloride for Agricultural Market
Market size, share, segmentation and regional forecast.
$665M market · 2025 base year
View reportCalcium Chloride Hexahydrate Market
Market size, share, segmentation and regional forecast.
$420M market · 2025 base year
View reportCalcium Chloride Powder Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.